Invacare Corporation Announces Financial Results For The Fourth Quarter And Full Year Ended December 31, 2020.

ORATION ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2020.
Q4 SALES $224 MILLION VERSUS REFINITIV IBES ESTIMATE OF $215.6 MILLION.
PROVIDES 2021 GUIDANCE AND OUTLOOK.
SEES 2021 CONSTANT CURRENCY NET SALES GROWTH IN RANGE OF 4% TO 7%.
SEES 2021 ADJUSTED EBITDA IMPROVEMENT OF 41%, TO $45 MILLION.
QTRLY LOSS PER SHARE $0.15.
QTRLY ADJUSTED.
LOSS PER SHARE $0.10.
Q4 EARNINGS PER SHARE VIEW $-0.20 -- REFINITIV IBES DATA.
FY2021 REVENUE VIEW $892.7 MILLION -- REFINITIV IBES DATA.